BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38175436)

  • 1. Two cases of mycosis fungoides with large cell transformation with KMT2A rearrangements.
    Wadsworth PA; Lawrence L; Suarez CJ; Saleem A; Khodadoust MS; Kim YH; Rieger KE; Fernandez-Pol S
    J Hematop; 2023 Dec; 16(4):227-234. PubMed ID: 38175436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
    Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
    Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
    Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
    Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphoma presenting as mycosis fungoides with a T-/null-cell phenotype: report of two cases.
    Bekel L; Chaby G; Lok C; Dadban A; Chatelain D; Ingen-Housz-Oro S; Ortonne N
    Br J Dermatol; 2015 Jun; 172(6):1637-1641. PubMed ID: 25420682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringotropic Mycosis Fungoides: A Variant of Folliculotropic or a Distinct Subtype of Adnexotropic Mycosis Fungoides?
    Nussbaum D; Eleryan M; Samaan C; Glass F; Prussick R
    J Drugs Dermatol; 2022 Dec; 21(12):1362-1364. PubMed ID: 36468959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T-cell lymphoma. Refinement in the application of controversial histologic criteria.
    Glusac EJ; Shapiro PE; McNiff JM
    Dermatol Clin; 1999 Jul; 17(3):601-14, ix. PubMed ID: 10410861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rare variants of cutaneous T-cell lymphomas].
    Goerdt S; Trautmann C; Kütting B; Ramaker J; Schmuth M; Thiel E; Luger T; Stein H; Orfanos CE
    Hautarzt; 1996 Feb; 47(2):96-105. PubMed ID: 8868452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycosis fungoides--type cutaneous T-cell lymphoma arising before 30 years of age. Immunophenotypic, immunogenotypic and clinicopathologic analysis of nine cases.
    Burns MK; Ellis CN; Cooper KD
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):974-8. PubMed ID: 1479104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
    Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epitheliotropic lymphomas: better identification for improved treatment].
    Bagot M
    Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma/delta T-cell lymphoma with mycosis fungoides-like clinical course transforming to "T-cell-receptor-silent" aggressive lymphoma: Description of one case.
    Tomasini D; Croci GA; Hotz A; Cione S; Cecchetti C; Ciambelli F; Crivelli F
    J Cutan Pathol; 2021 Sep; 48(9):1197-1203. PubMed ID: 34002416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
    Bakels V; van Oostveen JW; van der Putte SC; Meijer CJ; Willemze R
    Am J Pathol; 1997 Jun; 150(6):1941-9. PubMed ID: 9176388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of phenotypic switch of primary cutaneous T cell lymphoma after treatment with an aggressive course and review of the literature.
    Marks E; Shi Y; Wang Y
    Virchows Arch; 2019 Nov; 475(5):637-648. PubMed ID: 31218405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics of Cutaneous T-Cell Lymphomas.
    Hara N; Sawada Y
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulomatous slack skin disease: a review, in comparison with mycosis fungoides.
    Shah A; Safaya A
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1472-8. PubMed ID: 22435618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC).
    Kempf W; Ostheeren-Michaelis S; Paulli M; Lucioni M; Wechsler J; Audring H; Assaf C; Rüdiger T; Willemze R; Meijer CJ; Berti E; Cerroni L; Santucci M; Hallermann C; Berneburg M; Chimenti S; Robson A; Marschalko M; Kazakov DV; Petrella T; Fraitag S; Carlotti A; Courville P; Laeng H; Knobler R; Golling P; Dummer R; Burg G;
    Arch Dermatol; 2008 Dec; 144(12):1609-17. PubMed ID: 19075143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.
    Franceschi J; Ehret M; Visseaux L; Durlach A; Barbe C; Durot É; Grange F
    Acta Derm Venereol; 2022 Mar; 102():adv00676. PubMed ID: 35083494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.